Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2009-07-29 Board/Management Inform…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
STOLZ EMPLOYMENT CONTRACT TERMINATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated July 29, 2009, reporting the termination of an employment contract with the company's CFO. It details changes in employment terms and compensation but does not contain financial statements or detailed financial data. The primary content is about management personnel changes, specifically the termination of a material definitive agreement related to employment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management. The document length is short and focused on this personnel update, not a full report or financial disclosure.
2009-07-29 English
Major Shareholding Notification 2009
Major Shareholding Notification
2009-07-27 English
EQUITY 11 7.24.09 TRANCHE
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 27, 2009. It reports an unregistered sale of equity securities, specifically the purchase of Convertible Preferred Shares by a purchaser. The content focuses on a financing transaction involving equity securities and does not contain financial statements or detailed financial results. It is not an annual or quarterly report, nor an earnings release or management discussion. The primary subject is an update on capital raising activity and changes in capital structure. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 4171 characters, which is consistent with a typical 8-K filing for such an event, not a report publication announcement or regulatory filing fallback. Confidence is high due to clear mention of equity sales and financing terms.
2009-07-27 English
DMG AGREEMENTS 8-KA
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filing with the SEC, dated July 23, 2009, reporting the entry into a material definitive agreement and unregistered sales of equity securities. It details a consulting agreement involving issuance of common stock as payment. The content focuses on financing and capital structure changes through issuance of shares for services. It is not an annual or quarterly report, audit, earnings release, or management discussion. The primary subject is related to capital/financing activities, specifically issuance of shares for consulting services. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 3410 characters, which is consistent with a typical 8-K filing of this nature, not a report publication announcement or regulatory filing fallback.
2009-07-24 English
DMG ADVISORS AGREEMENTS
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement (a consulting agreement) and unregistered sales of equity securities. There is no financial statement or detailed financial performance data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a call transcript, earnings release, or any other report type. The document is an announcement of a material contract and equity issuance, which fits best under Capital/Financing Update (CAP). The document length is 3408 characters, which is typical for an 8-K filing. Therefore, the classification is CAP with high confidence.
2009-07-23 English
ECOLOGY S-1 JUNE '09
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used to register securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the securities being offered, risk factors, use of proceeds, plan of distribution, and other disclosures typical of a registration statement prospectus. This is not an annual report, earnings release, or any other type of financial report but a capital raising filing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains substantive content related to the offering, not just an announcement or certification, so it is not RPA or RNS.
2009-06-22 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.